Form 4: Bio-Techne Corp Executive William Geist Reports Changes in Beneficial Ownership
SEC Form 4
William Geist, President of Protein Sciences at Bio-Techne Corp, filed a Form 4 detailing changes in his beneficial ownership of company stock and derivative securities.
Summary
- On August 19, 2024, William Geist, President of Protein Sciences at Bio-Techne Corp, reported changes in his beneficial ownership of the company's securities.
- The report details the acquisition of performance restricted stock units, restricted stock units, and stock options.
- It also clarifies the vesting schedules for previously reported restricted stock units and stock options.
- The filing includes information on stock options with exercise prices ranging from $74.91 to $100.39 and various vesting dates.
- The report was filed by Andrew Nick as Attorney-in-Fact for William Geist pursuant to a previously filed Power of Attorney.
Sentiment
Score: 6
Explanation: The sentiment is neutral as it's a standard regulatory filing detailing changes in ownership. The acquisitions of stock and options could be seen as a positive sign of management's confidence, but it's a routine occurrence.
Positives
- The filing indicates continued investment and alignment of executive interests with the company through stock and option grants.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders. This allows investors to track executive compensation and potential alignment with shareholder interests.
Stakeholder Impact
- The filing provides transparency to shareholders regarding executive compensation and ownership.
Key Dates
| Date | Description |
|---|---|
| 02/01/2023 | Options to purchase 3,980 shares vest. |
| 02/01/2025 | 3,320 restricted stock units vest and options to purchase 3,980 shares vest. |
| 02/01/2024 | Options to purchase 3,976 shares vest. |
| 02/01/2026 | Options to purchase 3,976 shares vest. |
| 08/15/2023 | Options to purchase 7,400 shares vest. |
| 08/15/2024 | Earliest Transaction Date; Options to purchase 7,400 shares vest; Options to purchase 7,515 shares vest. |
| 08/15/2025 | Vesting date for performance restricted stock units, options to purchase 7,400 shares vest; Options to purchase 7,515 shares vest; Options to purchase 5,301 shares vest; 2,623 restricted stock units vest. |
| 08/15/2026 | Vesting date for performance restricted stock units, options to purchase 7,400 shares vest; 7,514 shares vest; Options to purchase 5,301 shares vest; 2,623 restricted stock units vest. |
| 08/15/2027 | Vesting date for performance restricted stock units, options to purchase 7,515 shares vest; Options to purchase 5,301 shares vest; 2,623 restricted stock units vest. |
| 08/15/2028 | Options to purchase 5,301 shares vest. |
| 08/15/2029 | Expiration date for stock options with exercise price of $100.39. |
| 08/15/2030 | Expiration date for stock options with exercise price of $84.61. |
| 08/15/2034 | Expiration date for stock options with exercise price of $74.91. |
| 11/01/2024 | 9,912 restricted stock units vest. |
| 11/01/2025 | 9,911 restricted stock units vest. |
| 08/19/2024 | Date of filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.